Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.260
-0.110 (-4.64%)
At close: Dec 5, 2025, 4:00 PM EST
2.270
+0.010 (0.44%)
After-hours: Dec 5, 2025, 4:10 PM EST
Anebulo Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Selling, General & Admin | 5.28 | 4.92 | 4.76 | 6.18 | 3.87 | 1.34 | |
| Research & Development | 3.8 | 4.3 | 3.55 | 5.6 | 2.96 | 2.27 | |
| Operating Expenses | 9.07 | 9.22 | 8.31 | 11.78 | 6.83 | 3.61 | |
| Operating Income | -9.07 | -9.22 | -8.31 | -11.78 | -6.83 | -3.61 | |
| Interest Expense | -0.34 | -0.38 | -0.15 | - | - | -0.01 | |
| Interest & Investment Income | 0.34 | 0.26 | 0.25 | 0.09 | 0.01 | 0 | |
| Other Non Operating Income (Expenses) | 0.63 | 0.86 | 0.01 | -0.04 | -0 | -26.63 | |
| Pretax Income | -8.44 | -8.48 | -8.2 | -11.73 | -6.83 | -30.25 | |
| Net Income | -8.44 | -8.48 | -8.2 | -11.73 | -6.83 | -30.25 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 8.21 | |
| Net Income to Common | -8.44 | -8.48 | -8.2 | -11.73 | -6.83 | -38.46 | |
| Shares Outstanding (Basic) | 38 | 34 | 26 | 25 | 23 | 14 | |
| Shares Outstanding (Diluted) | 38 | 34 | 26 | 25 | 23 | 14 | |
| Shares Change (YoY) | 45.22% | 30.97% | 2.98% | 7.41% | 71.49% | 13.44% | |
| EPS (Basic) | -0.22 | -0.25 | -0.32 | -0.47 | -0.29 | -2.83 | |
| EPS (Diluted) | -0.22 | -0.25 | -0.32 | -0.47 | -0.29 | -2.83 | |
| EBIT | -9.07 | -9.22 | -8.31 | -11.78 | -6.83 | -3.61 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.